NFA
DRTX

Nationwide Fund Advisors’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Nationwide Fund Advisors’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-44,186
Closed -$560K – 3408
2014
Q3 		$560K Buy
44,186
+2,225
+5% +$33.2K ﹤0.01% 2146
2014
Q2 		$715K Buy
41,961
+1,931
+5% +$28.8K ﹤0.01% 2062
2014
Q1 		$539K Hold
40,030
– – ﹤0.01% 2024
2013
Q4 		$512K Buy
40,030
+29,561
+282% +$310K ﹤0.01% 2231
2013
Q3 		$95K Buy
10,469
+1,374
+15% +$11.4K ﹤0.01% 2947
2013
Q2 		$65K Buy
+9,095
New +$66.8K ﹤0.01% 2913

Nationwide Fund Advisors's DRTX Position: Q4 2014 in Review

Nationwide Fund Advisors sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 44,186 shares — an estimated $560K sold.

Nationwide Fund Advisors first reported a position in DRTX in Q2 2013 and held it in 6 quarters. The position peaked at $715K in Q2 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

  • Nationwide Fund Advisors reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • Nationwide Fund Advisors sold 44,186 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $560K.
  • Nationwide Fund Advisors first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 6 quarters.
  • Nationwide Fund Advisors's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $715K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on Nationwide Fund Advisors's 13F filing for Q4 2014, filed 10 Feb 2015.